Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AOAH		ENSG00000136250	"Acyloxyacyl hydrolase"	P28039	7	36512941-36724549	"Enzymes, Metabolic proteins, Predicted secreted proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.3;lymphoid tissue: 64.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 77.9;Kupffer cells: 119.7;Macrophages: 77.1;Microglial cells: 233.3;monocytes: 67.5;NK-cells: 90.6;T-cells: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 298.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.8;NB-4: 26.5;THP-1: 20.2;U-937: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA021666, HPA026716"	Approved		Uncertain	Vesicles	"Secreted to blood"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA021666: AB_2670799, HPA026716: AB_2671960"	"unprognostic (3.55e-2)"	"unprognostic (4.03e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.14e-3)"	"unprognostic (5.42e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.35e-1)"	7.5	5.1	2.4	33.7	2.2	43.3	3.8	2.1	3.1	5.7	4.7	10.4	9.5	2.8	1.5	3.3	3.5	15.6	2.0	2.1	3.6	1.9	13.2	12.7	35.1	6.6	5.1	2.6	1.5	1.5	0.9	11.2	5.7	2.5	13.3	0.8	3.7	2.8	0.5	0.8	12.1	9.3	4.0	64.9	7.0	1.3	5.1	13.9	1.8	0.9	15.1	13.9	1.3	8.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.6	0.0	0.0	0.0	3.8	0.0	0.3	0.1	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.6	26.5	0.1	0.0	0.0	0.5	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	8.9	0.0	1.8	298.5	97.8	43.6	251.9	9.0	2.6	2.2	30.7	183.1	0.3	4.8	37.3	97.9	106.8	113.2	2.7	0.7	207.3	2.4	2.2	2.1	3.1	2.1	3.6	6.6	5.1	5.7	4.0	5.1	8.6	1.3	0.0	9.6	1.3	3.6	0.8	0.1	0.0	0.0	1.1	0.6	1.7	0.5	1.5	2.5	0.0	0.0	0.2	77.9	9.2	1.9	0.3	0.6	0.4	0.3	1.4	15.5	16.0	12.4	0.0	0.2	3.1	2.6	0.4	5.1	0.7	2.5	0.9	32.8	0.0	8.1	0.3	0.0	119.7	20.3	1.2	0.0	77.1	0.0	233.3	67.5	2.8	90.6	12.1	38.6	0.0	3.8	0.4	13.6	0.1	0.3	0.5	0.7	0.3	0.0	0.3	0.5	0.0	0.1	0.4	0.3	0.1	54.1	0.6	0.9	0.2
ARHGAP9	"10C, MGC1295"	ENSG00000123329	"Rho GTPase activating protein 9"	Q9BRR9	12	57472264-57488814	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 119.7;lymphoid tissue: 100.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 171.0;Early spermatids: 96.8;NK-cells: 123.6;Spermatocytes: 89.0;T-cells: 108.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 388.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 27.6;HMC-1: 116.2;MOLT-4: 22.5;NB-4: 22.1;THP-1: 34.9;U-937: 27.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA078822			Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Cell Junctions"	"HPA078822: "	"unprognostic (1.02e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.91e-2)"	"prognostic favorable (6.61e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.79e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.90e-9)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"	10.8	4.2	4.2	34.3	6.1	119.7	4.1	8.1	11.1	2.6	4.7	7.7	8.2	3.4	1.6	4.6	7.4	10.5	3.9	4.4	5.3	5.1	7.5	22.0	56.9	7.8	5.8	1.6	3.5	0.6	2.2	5.2	8.8	4.3	10.7	0.5	4.7	1.8	1.3	2.2	37.6	5.9	5.6	100.7	8.8	19.3	6.1	34.9	4.5	6.4	60.7	9.5	3.6	6.4	0.2	0.0	0.2	0.5	0.0	0.0	0.1	0.4	0.5	0.1	0.2	0.1	0.0	14.3	0.3	0.3	0.0	0.2	0.4	0.0	0.0	0.7	0.0	27.6	0.1	0.0	1.1	16.4	116.2	0.7	0.0	0.0	0.3	0.2	0.0	14.3	0.5	7.9	0.0	0.0	22.5	22.1	1.0	0.0	0.0	9.1	10.2	4.6	0.0	0.1	3.9	3.0	0.0	0.0	0.4	0.5	0.0	34.9	0.9	0.2	0.3	0.1	0.1	9.2	7.2	13.3	0.3	27.3	0.5	51.9	86.1	243.4	43.3	89.2	30.0	35.9	47.3	39.6	72.1	44.0	61.9	46.0	388.9	68.2	71.0	97.4	63.6	70.8	4.2	6.1	8.1	11.1	4.4	5.3	7.8	5.8	8.8	5.6	6.1	6.4	2.2	0.0	14.2	1.0	49.1	1.5	0.2	0.0	1.8	0.2	1.6	2.9	2.1	1.5	1.3	0.0	2.1	0.4	171.0	0.6	0.0	0.2	96.8	0.6	0.8	1.5	0.0	11.6	3.7	0.0	0.6	2.4	4.6	0.8	12.0	0.0	3.6	1.2	43.5	0.0	1.9	0.5	0.0	39.0	19.7	44.8	1.8	35.1	0.0	8.4	34.8	0.0	123.6	0.0	0.2	0.2	0.1	0.0	50.8	0.2	0.0	0.3	2.2	0.7	0.0	0.6	1.2	89.0	17.5	0.4	1.4	0.3	108.2	0.3	0.4	0.1
BTN2A2	"BT2.2, BTF2, BTN2.2"	ENSG00000124508	"Butyrophilin subfamily 2 member A2"	Q8WVV5	6	26383096-26394874	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 30.3;Plasma cells: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 72.8;U-266/70: 58.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA051504	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	Mitochondria		"HPA051504: AB_2681510"	"prognostic favorable (1.01e-4)"	"unprognostic (4.93e-3)"	"unprognostic (1.37e-2)"	"unprognostic (6.78e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-3)"	7.2	13.5	5.4	21.9	6.9	4.3	8.7	14.4	6.0	7.9	21.2	8.0	7.2	10.2	7.5	5.1	8.4	8.5	4.9	6.8	5.9	7.5	6.1	16.2	32.1	7.5	6.9	10.4	5.2	17.5	5.7	4.0	7.8	8.3	10.5	2.9	12.1	6.8	2.8	11.0	11.3	10.9	6.5	21.8	10.4	6.1	6.2	15.2	7.5	4.2	36.6	8.2	6.9	6.9	10.6	6.6	13.2	14.2	4.4	6.8	0.9	11.4	29.7	17.4	30.0	4.2	4.1	9.6	12.1	20.5	14.1	9.5	10.7	8.7	23.1	29.9	17.9	15.0	13.2	8.4	9.1	3.4	5.1	14.5	2.7	33.5	11.3	20.7	16.3	18.5	12.3	72.8	7.9	4.6	12.1	4.4	5.0	0.4	6.6	28.1	18.7	29.8	12.7	5.9	12.6	17.6	7.4	2.8	31.1	7.5	13.5	6.6	19.5	6.4	7.3	5.6	17.7	58.9	38.8	16.9	6.4	13.4	16.3	2.1	13.7	2.4	6.1	14.6	5.8	24.1	5.0	5.7	23.9	29.4	4.1	5.1	12.4	8.7	6.3	9.7	10.3	7.9	5.4	6.9	14.4	6.0	6.8	5.9	7.5	6.9	7.8	6.5	6.2	6.9	8.1	9.6	12.6	0.0	30.3	3.8	7.3	6.5	6.2	0.6	5.2	5.1	2.5	2.8	8.5	3.7	0.0	2.3	15.0	0.6	0.0	8.6	0.4	8.8	4.5	13.1	1.8	3.6	0.0	5.6	0.8	5.0	3.6	7.5	19.6	9.6	6.1	3.8	8.4	0.0	0.0	7.8	12.2	16.0	24.2	0.6	6.5	17.1	7.2	0.0	15.4	14.3	7.2	0.0	0.0	8.3	0.8	4.9	30.7	6.4	2.6	2.3	10.2	0.7	0.0	5.0	4.4	0.3	1.5	4.5	4.5	1.0	10.0	10.6	2.1	4.2
C5orf58		ENSG00000234511	"Chromosome 5 open reading frame 58"	C9J3I9	5	170232447-170252575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	35	"testis: 216.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 1.3"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	12	"U-266/84: 85.6"					"Not detected"	"Not detected"									NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (9.24e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.33e-6)"	"unprognostic (1.01e-1)"	"unprognostic (5.61e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.29e-10)"	"unprognostic (4.83e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.94e-2)"	"unprognostic (8.27e-2)"	3.1	0.7	0.1	2.7	0.3	6.2	2.5	0.2	2.2	1.3	0.4	0.8	0.6	0.5	0.0	0.4	0.7	1.1	0.9	0.1	0.1	0.6	1.0	4.9	2.2	0.8	0.5	0.4	0.3	0.0	0.6	1.2	1.1	1.0	0.0	0.0	1.9	0.0	0.5	0.9	1.4	0.0	0.4	3.6	0.6	216.4	0.8	0.0	0.9	0.0	0.1	0.9	1.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	3.5	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.9	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	6.9	0.8	0.0	0.0	0.0	0.0	0.0	2.6	85.6	0.0	0.0	1.0	0.0	0.0	0.2	0.5	0.6	0.3	0.4	0.0	0.4	0.6	0.0	0.0	0.3	0.9	1.0	0.6	0.3	0.0	0.0	0.0	0.1	0.3	0.2	2.2	0.1	0.1	0.8	0.5	1.1	0.4	0.8	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CD244	"2B4, NAIL, NKR2B4, Nmrk, SLAMF4"	ENSG00000122223	"CD244 molecule"	Q9BZW8	1	160830160-160862887	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.0;lymphoid tissue: 16.8"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 28.4;Kupffer cells: 17.7;NK-cells: 66.9;T-cells: 21.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	4	"basophil: 472.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 472.1"	"Cell line enhanced"	"Detected in some"		"HEL: 20.6;HMC-1: 69.4;NB-4: 14.4;U-937: 28.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA		280000	"Cluster 46: Basophils - DNA binding"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (6.11e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.95e-6)"	"unprognostic (5.79e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.93e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.40e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.79e-1)"	2.1	0.4	0.3	3.7	0.4	10.0	0.4	0.3	0.5	0.3	0.3	1.1	3.0	0.3	0.3	0.4	0.5	1.0	0.6	0.4	0.3	0.3	4.2	3.3	3.4	0.4	0.3	1.0	0.1	0.1	0.1	0.4	0.3	0.4	1.4	0.0	1.1	0.4	0.3	0.3	2.8	1.1	0.3	16.8	1.0	2.7	0.3	2.8	0.2	0.2	2.0	1.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.4	6.8	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	2.1	14.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	2.6	1.1	0.1	0.0	28.7	0.0	472.1	43.3	107.9	71.3	59.1	35.2	0.3	3.7	39.7	41.0	0.2	5.3	36.0	3.1	78.5	73.6	2.4	0.2	70.7	0.3	0.4	0.3	0.5	0.4	0.3	0.4	0.3	0.3	0.3	0.3	0.4	0.1	3.2	6.1	0.3	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	5.2	0.0	0.1	0.2	0.0	2.1	0.7	1.7	0.0	0.3	0.5	0.1	3.8	0.0	0.7	0.2	0.6	0.0	0.1	0.0	0.0	17.7	3.1	2.4	1.8	8.3	0.0	0.0	8.5	0.0	66.9	0.0	0.2	0.0	0.0	2.2	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.2	0.1	0.0	0.1	0.0	21.9	0.5	0.0	0.0
CD7	"GP40, LEU-9, Tp40, TP41"	ENSG00000173762	"CD7 molecule"	P09564	17	82314868-82317608	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.6;lymphoid tissue: 53.7"	"Group enriched"	"Detected in many"	9	"dendritic cells: 625.0;NK-cells: 1299.7;T-cells: 527.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 231.5"	"Group enriched"	"Detected in many"	22	"NK-cells: 231.5;T-cells: 71.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 52.0;JURKAT: 26.7;MOLT-4: 119.2"	"Region enhanced"	"Detected in some"		"cerebral cortex: 3.2"	"Not detected"	"Not detected"			"CAB002594, HPA039079"	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB002594: , HPA039079: AB_2676337"	"unprognostic (3.14e-3)"	"prognostic favorable (5.51e-4)"	"unprognostic (1.89e-2)"	"prognostic favorable (2.03e-5)"	"unprognostic (7.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.69e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (7.75e-11)"	"unprognostic (4.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.55e-3)"	8.2	1.3	0.7	32.9	0.8	28.6	2.6	0.8	1.3	2.5	0.9	7.3	12.4	3.0	0.4	3.9	3.9	3.2	1.8	0.6	1.1	7.1	7.7	17.1	36.8	1.4	0.8	0.8	1.2	0.1	1.4	3.3	1.0	4.4	1.9	0.0	3.1	1.0	0.8	1.7	21.1	1.1	1.2	53.7	8.1	0.6	1.1	48.8	3.5	0.1	14.8	3.9	3.9	1.2	0.0	0.0	0.0	0.0	0.1	0.4	12.9	0.0	0.2	0.1	0.2	0.6	0.1	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.7	52.0	0.6	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	26.7	0.1	0.0	0.1	0.0	119.2	0.0	0.0	0.0	0.2	0.1	0.1	2.3	0.2	0.0	0.4	0.3	1.8	1.1	0.0	0.3	0.0	0.0	0.0	0.3	0.3	1.0	0.0	1.2	0.2	0.0	0.2	0.0	0.0	0.5	0.4	0.5	66.6	0.2	57.6	0.4	29.8	49.0	0.3	0.2	69.4	71.5	2.3	231.5	0.6	6.9	28.7	30.9	0.7	0.8	0.8	1.3	0.6	1.1	1.4	0.8	1.0	1.2	1.1	1.2	5.3	0.0	0.0	0.0	12.1	7.5	0.6	0.1	1.8	0.0	4.2	3.7	0.5	4.3	0.3	0.0	0.0	0.7	625.0	9.4	0.0	1.3	0.1	2.8	2.0	4.5	0.0	47.7	0.0	0.5	10.3	12.4	43.8	5.3	8.2	0.0	16.8	3.3	3.6	1.7	0.0	1.5	0.0	18.5	8.8	0.0	0.0	19.2	12.4	0.0	11.6	0.0	1299.7	0.0	0.0	0.1	5.8	0.0	82.7	3.8	8.1	1.4	0.5	0.0	0.0	0.5	3.9	0.0	1.3	1.0	4.4	1.9	527.4	0.0	2.1	3.8
CEACAM3	"CD66d, CGM1"	ENSG00000170956	"CEA cell adhesion molecule 3"	P40198	19	41796587-41811554	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"bone marrow: 44.3"	"Cell type enriched"	"Detected in some"	13	"Paneth cells: 56.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 289.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 289.3"	"Not detected"	"Not detected"											HPA011041	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"		"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA011041: AB_1078481"	"unprognostic (1.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.68e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.83e-1)"	0.9	0.1	0.0	5.1	0.0	44.3	0.1	0.0	0.9	0.3	0.3	0.3	0.0	0.2	0.0	0.4	0.3	0.3	0.3	0.0	0.0	0.1	0.6	1.8	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.0	5.1	0.1	0.0	0.0	0.6	0.1	1.2	0.4	1.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	4.2	0.0	0.0	19.3	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	289.3	0.0	45.8	0.0	0.0	3.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.2	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.1	0.8	0.0	0.0	0.3	0.0	3.3	0.0	1.4	0.0	4.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	56.4	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.4	0.4
CEP78	"C9orf81, FLJ12643"	ENSG00000148019	"Centrosomal protein 78"	Q5JTW2	9	78236062-78279690	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Cone-rod dystrophy, Deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 110.5;dendritic cells: 106.8;NK-cells: 249.3;Spermatocytes: 82.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 39.1"	"Group enriched"	"Detected in many"	5	"NK-cells: 39.1;T-cells: 18.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048846	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA048846: AB_2680537"	"unprognostic (4.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.13e-4)"	"unprognostic (6.75e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.27e-3)"	"unprognostic (4.93e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.34e-1)"	2.2	2.9	4.3	4.6	5.0	12.3	4.3	5.9	4.4	4.1	3.8	3.5	2.8	5.6	3.2	3.5	3.4	2.4	1.6	4.2	4.7	3.6	3.5	3.4	6.2	4.6	4.5	4.3	2.5	4.3	2.7	3.9	4.6	3.1	3.9	9.2	3.3	3.4	1.6	3.5	2.9	4.7	5.1	5.0	3.0	15.1	4.3	11.5	3.7	1.7	7.7	3.2	3.0	6.2	31.7	14.5	33.3	20.5	5.4	9.4	22.3	25.6	10.1	15.1	19.1	2.7	8.4	28.9	12.7	9.2	21.4	36.9	49.6	13.7	22.5	24.3	16.6	15.4	17.1	11.4	4.9	26.0	14.6	5.2	2.9	17.1	11.1	7.5	23.4	29.4	12.2	22.4	19.8	20.3	32.6	12.8	35.2	32.7	14.0	32.2	38.4	8.4	9.0	14.0	30.4	21.1	33.7	10.6	8.4	22.7	12.6	6.9	12.5	13.3	22.6	27.5	24.7	13.1	17.8	18.4	11.8	17.6	23.0	0.7	0.8	0.7	18.3	3.4	8.9	5.0	7.9	16.0	2.3	3.4	3.9	12.8	0.5	39.1	5.5	4.2	13.1	8.3	4.3	5.0	5.9	4.4	4.2	4.7	4.6	4.5	4.6	5.1	4.3	6.2	10.3	25.6	9.2	26.1	13.7	5.1	8.1	6.9	8.0	27.1	7.6	10.5	8.9	4.3	7.2	1.8	110.5	14.0	106.8	3.9	5.9	8.4	14.1	18.7	16.9	9.0	7.7	25.7	28.6	6.7	19.5	10.3	10.2	10.4	5.1	20.6	7.1	9.0	9.6	3.3	20.5	8.0	4.1	6.1	6.1	9.9	14.9	10.0	1.8	9.4	9.7	14.7	249.3	27.2	24.6	4.7	4.1	15.1	43.7	3.7	1.0	5.1	22.1	49.4	0.0	14.8	11.3	82.1	34.2	10.0	4.8	4.0	34.0	12.3	13.2	4.0
CERKL	RP26	ENSG00000188452	"Ceramide kinase like"	Q49MI3	2	181536672-181680665	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.1;retina: 16.6"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 18.8;Endometrial ciliated cells: 43.5;Proximal tubular cells: 13.4;Respiratory ciliated cells: 38.7;Rod photoreceptor cells: 22.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 9.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	28	"SCLC-21H: 58.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 14.5"	"HPA035443, HPA035444, HPA043203"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA035443: AB_2674625, HPA035444: AB_10672093, HPA043203: "	"unprognostic (7.52e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (5.25e-4)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.45e-2)"	1.2	0.5	0.3	0.2	0.6	0.0	1.0	9.7	0.4	3.1	6.0	2.3	0.2	0.8	0.3	0.5	7.8	0.7	0.5	0.8	0.6	8.0	1.3	5.1	0.9	1.8	2.0	0.3	0.7	0.6	0.7	0.1	1.8	1.0	0.3	16.6	1.0	0.2	0.4	0.4	6.8	0.2	1.8	17.1	1.2	0.5	0.4	0.4	0.9	0.3	1.9	1.3	1.2	1.8	0.0	0.8	0.0	0.0	0.1	0.3	0.0	0.1	0.3	0.3	0.4	0.0	0.3	0.2	0.0	0.3	2.0	0.0	0.4	0.3	0.4	0.0	0.0	0.6	0.5	0.1	0.3	0.6	0.0	0.5	0.9	0.3	0.7	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.8	0.4	0.0	0.4	1.2	0.0	0.0	0.9	0.0	58.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.1	0.8	0.0	0.0	0.3	0.0	0.0	0.9	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.6	9.7	0.4	0.8	0.6	1.8	2.0	1.8	1.8	0.4	1.8	0.0	3.2	0.5	0.3	0.0	0.0	0.1	1.0	0.0	0.5	0.0	0.0	0.7	1.5	4.9	0.0	18.8	0.0	1.5	0.0	9.8	0.0	4.6	43.5	0.7	0.3	1.8	0.0	6.8	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	2.0	0.0	0.0	2.8	0.0	0.3	0.0	0.0	0.1	2.5	0.0	0.5	0.2	0.0	0.0	0.0	0.4	0.0	2.7	13.4	38.7	22.8	0.0	0.2	0.5	0.4	0.9	0.0	0.0	0.0	0.6	0.0	1.2	0.0
DGKK		ENSG00000274588	"Diacylglycerol kinase kappa"	Q5KSL6	X	50365409-50470825	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	29	"adrenal gland: 3.4;brain: 12.2;pituitary gland: 6.1"	"Cell type enriched"	"Detected in some"	6	"NK-cells: 13.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"thalamus: 12.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"Hep G2: 34.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 19.8"	"Low region specificity"	"Detected in some"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (3.99e-1)"		"unprognostic (1.18e-1)"	"unprognostic (4.18e-3)"	"unprognostic (1.23e-1)"		"unprognostic (5.83e-3)"	"unprognostic (9.58e-2)"		"unprognostic (2.41e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.28e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.64e-3)"	0.0	3.4	1.3	0.0	5.1	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.8	2.3	0.0	0.0	0.0	6.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	5.1	0.0	2.9	0.1	4.5	0.8	2.3	1.1	0.4	12.2	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.0	0.1	0.0	13.4	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1
EOMES	TBR2	ENSG00000163508	Eomesodermin	O95936	3	27715949-27722711	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 8.4;lymphoid tissue: 15.0"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 43.6;Erythroid cells: 16.8;NK-cells: 93.7;T-cells: 31.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Region enriched"	"Detected in single"	13	"cerebellum: 8.4"	"Group enriched"	"Detected in many"	7	"gdT-cell: 16.5;MAIT T-cell: 26.2;memory CD8 T-cell: 19.5;naive CD8 T-cell: 11.9;NK-cell: 33.0"	"Group enriched"	"Detected in many"	107	"NK-cells: 33.0;T-cells: 26.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.4;JURKAT: 8.3;SCLC-21H: 3.9"	"Region enriched"	"Detected in many"	8	"olfactory bulb: 77.5"	"Group enriched"	"Detected in some"	27	"cerebellum: 30.2;olfactory bulb: 12.7"	HPA028896	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA028896: AB_10601370"	"unprognostic (1.53e-4)"	"unprognostic (5.95e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.60e-4)"	"unprognostic (4.13e-2)"	"unprognostic (9.63e-4)"	"unprognostic (4.29e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.45e-6)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.49e-2)"	1.0	0.6	0.2	3.2	0.1	1.8	0.6	8.4	0.4	0.4	0.4	0.7	0.4	0.8	0.8	0.3	0.4	1.6	0.3	0.2	0.3	0.4	2.4	2.2	15.0	0.2	0.3	0.5	0.3	0.1	0.2	0.4	0.6	0.5	0.8	1.6	0.9	0.1	0.1	0.2	1.4	0.4	0.3	12.8	1.3	0.4	0.2	1.5	0.5	0.1	5.4	1.3	0.4	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.6	1.3	0.0	7.4	1.1	0.0	0.0	0.5	0.0	0.9	0.0	0.0	0.8	0.0	0.9	0.3	0.0	8.3	0.2	0.0	0.0	2.0	2.0	0.0	0.2	0.2	0.9	1.3	0.0	0.0	0.6	0.0	3.9	0.0	0.0	0.0	0.9	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	16.5	0.0	26.2	0.0	3.0	19.5	0.0	0.0	0.2	11.9	0.2	33.0	0.1	0.1	0.0	2.9	0.2	0.1	8.4	0.4	0.2	0.3	0.2	0.3	0.6	0.3	0.2	0.4	0.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.4	0.2	0.3	0.8	1.5	0.0	0.0	0.0	0.0	43.6	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	16.8	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0	2.2	1.6	0.2	0.0	0.0	0.0	0.0	3.1	0.7	0.0	0.3	1.3	1.8	1.0	1.1	0.1	93.7	0.0	0.0	0.0	0.0	0.4	9.8	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.0	2.0	0.0	0.1	0.0	31.5	0.0	0.0	0.0
FASLG	"APT1LG1, CD178, FasL, TNFSF6"	ENSG00000117560	"Fas ligand"	P48023	1	172659103-172666876	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Apoptosis, Transcription, Transcription regulation"	"Cytokine, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.7"	"Group enriched"	"Detected in some"	14	"dendritic cells: 43.4;NK-cells: 79.3;T-cells: 28.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 58.1"	"Group enriched"	"Detected in many"	9	"NK-cells: 41.5;T-cells: 58.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054959	Approved				"Secreted to blood"	NA	NA	73600		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"			"HPA054959: AB_2682650"	"unprognostic (1.09e-3)"	"unprognostic (1.41e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.54e-7)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.67e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.59e-6)"	"unprognostic (3.49e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.82e-3)"	0.3	0.8	0.1	1.0	0.2	2.8	0.6	0.1	0.2	0.4	0.1	0.8	1.9	0.5	0.7	0.3	0.3	1.1	0.3	0.2	0.1	0.3	1.1	2.0	5.7	0.3	0.2	0.3	0.1	0.0	0.1	0.2	0.2	0.5	0.9	0.0	0.9	0.3	0.1	0.4	1.4	0.3	0.0	4.1	1.5	0.2	0.1	0.6	0.2	0.0	1.8	0.8	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.5	0.1	0.0	58.1	0.2	35.5	0.0	11.5	31.4	0.1	0.0	2.2	25.0	1.9	41.5	0.1	0.0	0.2	14.9	0.1	0.2	0.1	0.2	0.2	0.1	0.3	0.2	0.2	0.0	0.1	0.4	0.4	0.0	2.5	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	43.4	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.3	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.3	1.2	0.0	0.0	0.6	1.8	0.0	0.9	0.0	79.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	28.8	0.0	0.0	0.1
FCRL3	"CD307c, FCRH3, IFGP3, IRTA3, SPAP2, SPAP2a, SPAP2b, SPAP2c, SPAP2d, SPAP2e"	ENSG00000160856	"Fc receptor like 3"	Q96P31	1	157674321-157700769	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 49.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 54.3;dendritic cells: 21.2;Early spermatids: 8.0;Late spermatids: 9.1;NK-cells: 30.9;T-cells: 12.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 35.3"	"Group enriched"	"Detected in many"	54	"B-cells: 35.3;NK-cells: 20.4;T-cells: 19.0"	"Cell line enriched"	"Detected in some"	7	"Daudi: 9.9"					"Low region specificity"	"Detected in some"			HPA048022	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA048022: AB_2732541"	"unprognostic (6.73e-3)"	"unprognostic (5.06e-4)"	"unprognostic (1.13e-2)"	"unprognostic (2.08e-4)"	"unprognostic (3.86e-1)"	"unprognostic (1.74e-5)"	"unprognostic (1.09e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.46e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.01e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.69e-2)"	0.4	0.0	0.0	14.1	0.0	1.1	0.1	0.0	0.0	0.1	0.0	1.1	0.3	0.2	0.1	0.1	0.1	1.0	0.2	0.0	0.0	0.2	0.8	0.9	49.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.2	0.0	0.8	0.0	0.1	0.0	8.7	0.1	0.0	27.5	1.5	0.2	0.0	4.6	0.4	0.1	36.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	19.0	0.0	1.8	30.3	2.6	13.2	0.0	35.3	0.2	8.3	0.4	20.4	0.0	0.0	11.3	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	54.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	8.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.1	0.0	0.0	1.2	0.0	9.1	0.0	0.4	0.0	1.0	0.9	0.0	30.9	0.5	0.0	0.0	1.1	0.0	3.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	12.4	0.0	0.0	0.0
GBP1		ENSG00000117228	"Guanylate binding protein 1"	P32455	1	89051882-89065360	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 88.0"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 183.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 131.4;BJ hTERT+ SV40 Large T+ RasG12V: 175.2;GAMG: 129.1"									CAB015450	Approved				"Intracellular and membrane"	NA	NA		110000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB015450: AB_2109333"	"unprognostic (3.43e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (8.32e-4)"	"unprognostic (9.56e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.67e-2)"	"prognostic favorable (5.04e-4)"	"unprognostic (8.36e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (5.12e-9)"	"unprognostic (4.67e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.01e-3)"	23.9	7.9	4.1	71.6	4.1	5.2	18.2	4.0	5.6	23.8	3.7	23.0	16.8	26.4	5.5	10.4	18.2	44.4	10.5	3.3	5.4	12.1	88.0	44.4	55.1	19.2	5.0	13.2	6.0	6.5	5.5	20.4	11.9	19.2	13.5	1.2	12.2	14.3	5.1	9.3	17.8	37.0	6.7	51.6	16.5	3.4	5.8	21.3	17.9	5.4	21.6	43.0	15.4	5.8	13.9	0.2	0.0	0.0	11.6	22.4	35.6	34.3	72.4	131.4	175.2	3.5	7.5	12.4	22.1	44.5	129.1	2.4	0.0	18.8	61.7	41.1	0.1	2.9	9.4	0.3	70.7	0.0	1.8	54.6	6.3	61.0	10.3	29.8	34.5	18.4	0.0	9.9	44.7	0.0	31.9	0.2	0.2	0.0	1.4	43.6	40.7	0.8	7.2	21.0	0.5	0.0	39.2	8.3	3.8	0.0	0.8	0.1	40.2	33.4	1.6	10.8	29.7	0.4	0.2	0.1	13.2	0.2	3.3	0.7	38.8	5.6	94.1	126.1	90.7	17.3	93.3	99.0	46.7	12.4	69.1	79.4	106.2	62.4	134.1	0.3	172.2	92.0	4.1	4.1	4.0	5.6	3.3	5.4	19.2	5.0	11.9	6.7	5.8	5.8	70.7	73.7	24.1	1.0	13.5	39.6	183.9	31.7	19.9	0.2	10.3	18.4	3.3	15.7	28.9	9.2	0.0	59.8	16.6	27.3	0.0	36.0	0.1	75.0	85.5	56.4	9.0	1.7	0.2	74.5	73.6	36.2	18.3	33.3	14.5	17.8	22.5	75.3	32.6	0.0	0.1	4.1	4.1	36.5	19.2	1.0	9.9	58.6	5.4	6.5	78.1	9.9	43.3	0.0	0.1	42.5	9.9	25.6	8.8	19.1	13.3	14.0	78.4	0.3	13.1	45.5	39.4	0.1	0.4	11.5	21.5	34.9	44.9	36.6	11.0	28.3
GZMB	"CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT"	ENSG00000100453	"Granzyme B"	P10144	14	24630954-24634267	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 68.2;lymphoid tissue: 37.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2050.2;NK-cells: 1704.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"plasmacytoid DC: 6765.2"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 6765.2"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 22.0"									"CAB000376, HPA003418"	Enhanced				"Secreted to blood"	NA	NA	2170		"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB000376: AB_323716, HPA003418: AB_1079020"	"prognostic favorable (7.27e-4)"	"unprognostic (2.82e-3)"	"unprognostic (8.54e-2)"	"prognostic favorable (1.58e-5)"	"unprognostic (2.07e-3)"	"unprognostic (1.48e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.25e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.10e-7)"	"unprognostic (1.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-3)"	8.2	1.7	1.2	17.8	1.3	68.2	2.1	1.2	3.9	1.2	1.4	2.5	2.3	7.1	1.6	3.8	1.5	6.5	1.8	1.2	7.9	1.5	4.1	15.3	37.1	1.5	1.5	0.3	1.0	0.7	0.7	3.3	1.6	1.4	2.2	0.0	2.3	1.4	2.0	0.4	4.4	4.3	1.4	28.9	3.5	0.5	1.8	9.7	1.9	1.5	34.6	18.5	1.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.7	2.8	9.9	3.0	5.3	1338.5	4.0	16.0	7.0	95.2	641.6	6.3	3.1	29.1	607.5	43.1	507.8	6.0	6765.2	2.7	1607.1	1.2	1.3	1.2	3.9	1.2	7.9	1.5	1.5	1.6	1.4	1.8	1.3	4.3	6.4	36.0	0.0	15.9	2.8	0.3	0.0	0.0	0.0	0.9	0.8	1.1	4.3	7.4	0.0	0.0	0.4	2050.2	0.6	0.0	1.6	0.0	0.4	0.5	2.7	0.0	11.8	0.0	0.0	0.1	5.1	9.2	0.5	17.7	0.0	4.2	1.2	0.2	0.0	0.0	0.6	0.0	4.8	9.0	0.2	0.0	27.1	42.7	1.0	11.6	0.0	1704.4	0.0	0.1	0.1	2.3	0.0	86.8	0.2	0.6	3.1	4.4	0.0	0.0	1.3	1.3	0.0	0.1	0.4	4.1	0.3	373.8	0.0	0.6	0.1
HCAR2	"GPR109A, HCA2, HM74A, NIACR1, Puma-g, PUMAG"	ENSG00000182782	"Hydroxycarboxylic acid receptor 2"	Q8TDS4	12	122701293-122703357	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	Apoptosis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.8;skin 1: 30.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 94.4;Basal prostatic cells: 84.7;Basal respiratory cells: 52.0;Basal squamous epithelial cells: 120.1;Ionocytes: 87.5;Langerhans cells: 124.0;Suprabasal keratinocytes: 106.1"	"Group enriched"	"Detected in many"	8	"cervical cancer: 12.6;head and neck cancer: 16.1;lung cancer: 6.4;urothelial cancer: 9.2"	"Region enriched"	"Detected in some"	5	"cerebral cortex: 5.9"	"Immune cell enriched"	"Detected in many"	5	"neutrophil: 176.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 176.7"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 118.4"									HPA028660	Approved		Supported	"Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (5.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.83e-4)"	"unprognostic (5.76e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.63e-2)"	22.2	0.3	0.1	9.8	0.2	22.1	7.6	0.1	5.9	8.9	0.2	0.7	0.9	0.2	0.3	40.8	0.7	0.8	0.9	0.3	0.1	3.9	2.9	11.9	0.6	0.1	0.1	0.1	0.2	5.5	0.3	4.5	1.2	3.4	0.3	0.2	14.2	14.7	0.2	30.2	1.0	0.3	0.1	25.9	1.5	2.7	0.2	10.5	0.5	1.9	10.2	6.9	14.0	0.1	4.5	0.4	0.1	0.1	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	118.4	0.0	7.3	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.3	0.1	3.8	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.0	19.5	0.2	0.0	0.4	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	38.7	2.5	2.6	0.0	5.3	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	176.7	0.0	23.9	0.0	0.0	1.4	0.1	0.2	0.1	5.9	0.3	0.1	0.1	0.1	1.2	0.1	0.2	0.1	0.4	0.0	4.3	0.0	0.5	94.4	84.7	52.0	120.1	0.5	3.4	1.1	0.1	0.0	40.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	24.9	0.4	0.2	1.2	0.0	0.0	0.0	0.0	26.3	2.4	0.0	0.3	2.5	0.0	0.0	0.0	3.7	0.0	0.0	0.0	87.5	4.1	124.0	2.7	0.0	17.8	8.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	8.5	0.1	0.0	0.1	1.4	0.0	0.1	47.2	106.1	2.6	1.5	0.0	0.0	32.5
HCAR3	"GPR109B, HCA3, HM74"	ENSG00000255398	"Hydroxycarboxylic acid receptor 3"	P49019	12	122714756-122716811	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.4;esophagus: 16.8;lymphoid tissue: 19.6;skin 1: 17.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 94.4;Basal prostatic cells: 81.1;Basal respiratory cells: 57.3;Basal squamous epithelial cells: 159.4;Langerhans cells: 57.4;Squamous epithelial cells: 66.9;Suprabasal keratinocytes: 106.3;Urothelial cells: 66.1"	"Group enriched"	"Detected in some"	4	"cervical cancer: 2.1;head and neck cancer: 2.5;lung cancer: 1.0;urothelial cancer: 1.9"	"Region enriched"	"Detected in single"	5	"cerebral cortex: 4.7"	"Group enriched"	"Detected in many"	6	"basophil: 58.6;neutrophil: 177.2;non-classical monocyte: 84.4"	"Group enriched"	"Detected in many"	50	"granulocytes: 177.2;monocytes: 84.4"	"Cell line enriched"	"Detected in some"	4	"RT4: 37.1"									HPA028660	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (2.32e-1)"	"unprognostic (5.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.28e-2)"	5.6	0.1	0.0	9.2	0.1	27.4	2.3	0.0	4.7	2.5	0.2	0.5	0.2	0.0	0.5	16.8	0.7	0.6	0.7	0.1	0.0	0.9	1.8	8.2	0.4	0.0	0.0	0.1	0.0	3.4	0.2	1.9	0.9	1.5	0.1	0.1	3.4	2.7	0.1	17.4	0.2	0.2	0.0	19.6	0.4	0.1	0.1	4.0	0.4	1.1	7.8	7.1	4.3	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	9.2	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	37.1	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.1	58.6	2.2	0.8	0.0	16.7	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	177.2	0.0	84.4	0.0	0.0	2.9	0.0	0.1	0.0	4.7	0.1	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.1	3.2	6.7	0.0	0.7	94.4	81.1	57.3	159.4	0.2	0.7	0.3	0.0	0.0	24.6	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	21.5	1.4	0.0	0.1	3.8	0.0	0.0	0.1	6.0	0.0	0.0	0.0	12.2	10.6	57.4	0.2	0.0	20.1	8.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	14.7	0.0	0.1	2.2	0.2	0.0	0.0	1.4	0.1	0.0	66.9	106.3	13.8	1.0	0.0	0.0	66.1
HLA-F		ENSG00000204642	"Major histocompatibility complex, class I, F"	P30511	6	29722775-29738528	"Plasma proteins, Predicted membrane proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 188.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 220.4;NK-cells: 339.8;Proximal enterocytes: 298.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"A-431: 36.3;GAMG: 13.5;HEK 293: 12.5;HEL: 8.9;HHSteC: 10.1;JURKAT: 7.6;U-266/70: 8.5;U-937: 13.6"															NA	NA		15000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (3.07e-3)"	"unprognostic (5.16e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.21e-3)"	"unprognostic (2.43e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-2)"	58.0	36.6	1.3	1.9	1.6	1.8	52.2	1.0	2.0	43.4	1.1	60.4	28.8	41.2	2.3	21.0	38.1	18.7	40.0	1.0	1.2	35.6	29.9	91.8	41.4	1.6	1.3	19.8	14.4	0.2	25.7	1.1	1.5	31.5	2.7	1.0	28.1	2.2	14.7	40.8	101.4	0.3	1.4	188.3	36.2	7.3	1.2	1.9	40.6	0.0	10.2	30.0	38.5	1.6	36.3	0.0	0.0	0.1	0.2	0.8	0.2	0.0	0.0	0.1	0.8	0.0	0.2	0.1	0.0	0.1	13.5	1.4	0.0	1.3	0.0	0.8	12.5	8.9	0.4	0.1	10.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	7.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.4	2.3	0.0	0.0	0.1	0.0	0.5	1.7	0.0	0.0	0.6	0.1	0.1	1.2	0.2	8.5	1.9	0.1	0.0	13.6	0.1	54.3	16.8	42.8	34.9	21.6	25.9	19.4	22.8	28.5	1.1	16.9	21.5	21.2	31.9	32.7	32.0	6.5	25.1	15.2	1.3	1.6	1.0	2.0	1.0	1.2	1.6	1.3	1.5	1.4	1.2	1.6	180.1	38.5	64.7	2.6	133.4	40.9	32.7	58.4	12.5	1.5	19.9	17.0	12.2	50.1	37.0	7.3	2.1	0.4	220.4	214.3	1.9	75.9	2.2	8.6	13.9	110.6	22.8	29.9	2.7	87.8	0.8	27.3	69.8	14.2	50.0	3.4	71.7	30.4	55.3	0.0	6.2	119.2	69.2	96.9	50.3	1.4	28.3	99.4	28.4	12.2	207.1	4.6	339.8	4.5	0.7	71.4	122.0	21.1	92.3	41.8	298.8	4.9	34.3	1.3	46.0	20.7	36.2	10.0	3.9	11.4	37.5	0.3	198.9	24.9	90.8	62.5
HSH2D	"ALX, FLJ14886, HSH2"	ENSG00000196684	"Hematopoietic SH2 domain containing"	Q96JZ2	19	16134028-16158575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.0;lymphoid tissue: 37.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 78.5;dendritic cells: 101.3;Gastric mucus-secreting cells: 40.2;NK-cells: 82.4;Plasma cells: 134.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 232.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 41.0;HL-60: 43.5;HMC-1: 56.4;NB-4: 140.1;RPMI-8226: 63.2;U-266/84: 41.9;U-937: 137.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036616			Approved	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA036616: AB_10671962"	"unprognostic (1.69e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (9.46e-6)"	"unprognostic (1.06e-1)"	"unprognostic (5.50e-3)"	"unprognostic (5.21e-3)"	"unprognostic (9.35e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.21e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (6.49e-6)"	"unprognostic (9.17e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (3.47e-5)"	1.6	0.7	0.5	16.8	1.1	47.0	3.3	1.1	1.1	3.0	1.2	9.8	12.7	1.3	1.8	1.7	3.2	5.4	0.4	0.5	0.4	1.5	2.2	5.6	27.2	1.5	0.7	0.5	4.3	2.3	4.0	1.5	1.1	5.1	9.3	0.3	9.5	2.9	0.4	0.4	20.5	1.0	0.7	37.7	12.7	0.4	1.0	8.7	2.6	1.2	35.7	7.5	0.7	2.8	15.0	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	2.2	21.3	41.0	0.6	0.0	0.8	0.7	0.0	0.6	0.0	2.3	0.1	0.6	0.5	2.6	0.0	43.5	56.4	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.1	37.4	0.0	9.0	0.1	140.1	0.0	5.5	0.0	3.0	0.0	63.2	0.4	5.6	0.1	0.1	0.0	1.3	0.3	0.0	0.3	15.9	0.2	0.1	0.1	0.2	0.2	5.7	41.9	23.6	0.2	137.3	0.0	232.1	15.5	100.9	17.1	22.0	15.8	56.4	7.6	11.2	25.5	35.8	6.9	9.2	182.6	85.2	38.8	7.6	13.0	16.7	0.5	1.1	1.1	1.1	0.5	0.4	1.5	0.7	1.1	0.7	1.0	2.8	1.0	3.2	8.9	0.0	78.5	0.3	1.2	3.0	0.6	0.0	3.6	1.9	0.6	5.7	11.3	5.5	0.0	2.6	101.3	18.9	0.0	6.7	0.0	4.5	1.5	0.8	8.4	32.2	0.5	5.1	4.1	0.7	40.2	7.9	6.3	0.1	1.4	0.6	1.1	0.0	0.4	19.1	2.0	3.4	2.4	0.1	0.0	7.3	10.6	1.0	10.7	0.0	82.4	1.0	0.3	9.7	18.0	0.0	134.0	2.6	17.9	0.3	7.9	0.0	0.0	1.1	0.7	0.1	0.5	0.1	0.1	3.4	31.0	0.2	9.3	4.1
KLRB1	"CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A"	ENSG00000111796	"Killer cell lectin like receptor B1"	Q12918	12	9594551-9607916	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.4;lymphoid tissue: 36.4"	"Group enriched"	"Detected in many"	9	"dendritic cells: 642.3;NK-cells: 1855.8;T-cells: 790.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in all"		"MAIT T-cell: 2177.1"	"Group enriched"	"Detected in all"	140	"NK-cells: 756.7;T-cells: 2177.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA039113	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA039113: AB_10674979"	"prognostic favorable (3.51e-5)"	"unprognostic (1.23e-3)"	"unprognostic (7.03e-3)"	"prognostic favorable (1.42e-5)"	"unprognostic (1.69e-1)"	"prognostic favorable (6.99e-5)"	"unprognostic (1.54e-3)"	"unprognostic (7.15e-3)"	"unprognostic (4.12e-1)"	"unprognostic (8.23e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (1.17e-2)"	3.1	1.7	0.7	17.8	0.8	47.4	5.1	0.3	0.8	4.2	0.2	7.7	10.7	1.6	1.4	3.2	1.5	10.7	0.7	0.6	0.7	1.4	11.3	6.7	20.1	0.6	0.6	1.0	0.4	0.2	0.3	1.4	0.6	2.1	8.1	0.1	0.8	1.0	0.7	0.8	20.1	1.6	0.6	28.9	10.1	0.6	0.6	5.7	1.3	0.9	36.4	10.6	1.3	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.3	0.0	0.4	0.2	9.5	2.2	1.1	519.7	2.1	2177.1	1.6	307.4	346.1	1.9	1.5	17.1	98.0	10.5	756.7	3.6	3.9	77.9	285.3	0.7	0.8	0.3	0.8	0.6	0.7	0.6	0.6	0.6	0.6	0.6	0.8	6.1	0.0	8.9	0.0	19.0	9.7	0.9	0.0	1.2	0.0	5.2	2.5	1.0	4.3	1.3	0.0	0.0	0.4	642.3	1.7	0.0	0.6	0.0	1.9	1.5	6.2	0.0	118.1	0.4	0.0	0.1	7.9	12.2	2.4	0.0	0.0	45.3	10.1	0.9	0.0	0.6	1.0	0.0	36.2	15.8	0.0	0.0	13.2	24.9	0.0	28.1	0.0	1855.8	2.5	0.1	0.0	3.3	0.0	23.0	1.1	0.9	2.0	0.0	0.0	0.0	1.6	4.1	0.0	0.1	1.2	8.8	1.0	790.5	0.0	2.0	1.3
KLRC3	NKG2-E	ENSG00000205810	"Killer cell lectin like receptor C3"	Q07444	12	10412315-10420595	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.9;brain: 2.1;lymphoid tissue: 4.0"	"Group enriched"	"Detected in some"	4	"dendritic cells: 19.2;Oligodendrocyte precursor cells: 36.2;T-cells: 15.9"	"Cancer enriched"	"Detected in single"	9	"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	6	"NK-cell: 63.1"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 63.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.4;GAMG: 2.8;HEL: 1.3;HeLa: 7.0;HSkMC: 1.2;SuSa: 1.3;U-698: 1.9"									"HPA039910, HPA062570"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA039910: , HPA062570: AB_2684795"	"unprognostic (8.92e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.32e-1)"	"unprognostic (5.07e-3)"		"unprognostic (2.48e-1)"	"unprognostic (3.22e-1)"		"unprognostic (9.12e-2)"		"unprognostic (3.52e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.15e-1)"		0.2	0.1	1.3	0.3	1.4	1.9	0.1	0.7	2.1	0.1	0.2	0.5	0.8	0.5	0.1	0.2	0.2	0.6	0.0	1.3	1.7	0.1	0.5	0.6	1.7	1.7	1.1	0.1	0.1	0.0	0.0	0.1	1.2	0.1	0.4	0.0	0.1	0.0	0.0	0.0	1.3	0.1	1.3	4.0	0.6	0.2	1.3	0.4	0.1	0.0	0.8	0.1	0.1	2.1	0.0	0.0	0.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.6	0.0	0.0	0.0	1.3	7.0	0.1	0.0	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.1	0.0	0.0	7.0	0.0	0.0	0.1	8.7	0.6	63.1	0.0	0.0	0.0	3.6	1.3	1.4	0.7	2.1	1.3	1.7	1.7	1.1	1.2	1.3	1.3	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.7	0.1	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	1.9	0.0	0.0	1.0	36.2	2.3	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.1
KRT72	"K6irs, K6IRS2, KRT6, KRT6IRS2"	ENSG00000170486	"Keratin 72"	Q14CN4	12	52585589-52601538	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skin 1: 10.5;testis: 23.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 26.3;Late spermatids: 67.5;Spermatocytes: 55.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065523	Enhanced					NA	NA				"Cluster 27: Brain & Skin - Unknown function"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA065523: AB_2685504"	"unprognostic (3.36e-1)"	"unprognostic (7.20e-2)"				"unprognostic (3.41e-2)"		"unprognostic (1.02e-1)"			"unprognostic (6.97e-2)"	"unprognostic (4.38e-3)"	"unprognostic (4.82e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.16e-2)"		"unprognostic (1.19e-1)"	0.1	0.1	0.0	0.7	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	10.5	2.2	0.0	0.0	2.2	0.0	23.7	0.0	0.5	0.1	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	26.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.5	1.5	0.1	0.0	0.0	0.1	0.0	12.3	0.0	0.1	0.0	2.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	55.9	0.2	0.0	0.4	0.0	0.3	0.0	0.1	0.0
KRT73	"K6IRS3, KRT6IRS3"	ENSG00000186049	"Keratin 73"	Q86Y46	12	52607570-52618559	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 17.0"	"Cell type enriched"	"Detected in some"	5	"NK-cells: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"naive CD4 T-cell: 8.8;naive CD8 T-cell: 3.1"	"Lineage enriched"	"Detected in single"	13	"T-cells: 8.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA044031	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 61: Skin - Cornification"		"Cluster 63: NK-cells & T-cells - Immune response"			"HPA044031: AB_10963434"		"unprognostic (2.23e-3)"				"unprognostic (6.54e-2)"					"unprognostic (3.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.11e-3)"		"unprognostic (4.94e-1)"			0.3	0.0	0.0	0.7	0.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	17.0	0.9	0.0	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.0	8.8	3.1	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	7.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
LIM2	"MP17, MP19"	ENSG00000105370	"Lens intrinsic membrane protein 2"	P55344	19	51379909-51387974	"Disease related genes, Human disease related genes, Predicted membrane proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"NK-cells: 20.6"	"Cancer enriched"	"Detected in single"	40	"testis cancer: 18.3"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	7	"gdT-cell: 11.3"	"Lineage enriched"	"Detected in many"	7	"T-cells: 11.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"			"Cluster 63: NK-cells & T-cells - Immune response"									"unprognostic (5.25e-2)"							"unprognostic (1.09e-3)"		"unprognostic (1.21e-1)"			0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.2	1.4	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0
MX2	MXB	ENSG00000183486	"MX dynamin like GTPase 2"	P20592	21	41361999-41409393	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.1;Gastric mucus-secreting cells: 40.8;Macrophages: 57.6;monocytes: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 150.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 150.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 143.6;BJ hTERT+ SV40 Large T+ RasG12V: 136.9;MOLT-4: 56.8;U-266/84: 84.2;U-937: 90.6"					"Low region specificity"	"Detected in all"			HPA030235	Uncertain					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA030235: AB_10601970"	"unprognostic (1.88e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.90e-3)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (2.50e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.38e-14)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.16e-2)"	12.5	1.4	0.5	16.3	0.6	13.2	9.7	0.6	1.0	11.9	0.6	5.3	6.8	2.5	0.9	6.0	5.0	13.4	7.1	0.6	0.6	3.4	2.3	6.7	14.2	3.5	1.3	3.3	2.4	1.5	1.4	5.0	1.6	2.7	2.9	0.0	5.9	1.6	2.4	4.8	9.5	5.8	4.5	24.8	13.1	2.3	1.0	30.4	4.4	4.2	14.0	14.8	6.7	1.3	0.3	0.0	0.0	0.0	3.4	6.5	0.0	0.0	19.9	143.6	136.9	0.0	31.1	0.0	0.0	1.9	27.6	0.0	0.0	0.0	4.9	1.1	0.0	30.4	0.0	20.3	0.8	1.1	0.0	11.9	0.0	2.7	0.0	0.0	0.0	0.9	1.4	18.3	0.0	0.0	56.8	23.0	36.1	7.1	0.0	8.6	0.0	4.5	0.0	3.8	0.0	0.0	2.4	0.0	2.5	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	84.2	1.2	3.9	90.6	15.3	6.0	31.4	24.4	11.7	37.5	14.7	13.8	19.0	14.1	22.6	11.5	19.1	13.2	150.8	7.4	35.9	10.8	16.3	21.8	0.5	0.6	0.6	1.0	0.6	0.6	3.5	1.3	1.6	4.5	1.0	1.3	32.1	6.4	7.1	0.0	28.4	4.1	2.2	1.2	2.2	0.1	1.8	2.3	3.7	0.0	9.8	1.8	0.0	0.4	27.2	1.4	1.9	0.8	0.5	0.9	9.5	15.6	3.0	1.3	1.0	2.9	1.3	19.7	40.8	0.9	12.6	1.0	3.3	0.2	15.1	0.0	0.4	3.2	0.0	28.6	27.4	1.7	6.8	57.6	10.6	5.6	42.4	0.2	24.7	1.0	0.3	5.2	1.1	4.1	10.3	2.7	4.6	0.1	9.1	0.3	26.3	2.6	11.1	1.4	7.3	3.5	1.4	0.3	30.3	2.2	2.1	5.8
MYBL1	"A-myb, AMYB"	ENSG00000185697	"MYB proto-oncogene like 1"	P10243	8	66562175-66614247	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.1;testis: 11.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 127.3;NK-cells: 107.1;Plasma cells: 40.2;Spermatocytes: 35.8;T-cells: 89.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.9;MAIT T-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 82.5;BJ hTERT+ SV40 Large T+ RasG12V: 69.4;Daudi: 87.7;HBF TERT88: 113.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA008791	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA008791: AB_1078540"	"unprognostic (1.11e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.23e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.67e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.74e-3)"	"prognostic unfavorable (2.03e-8)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.87e-2)"	1.0	0.7	1.1	6.1	2.2	2.5	1.7	2.0	1.7	0.7	0.3	1.0	1.3	1.1	0.5	0.7	0.8	2.3	3.4	1.0	1.3	0.4	2.0	2.3	20.1	2.9	1.7	0.6	0.2	0.4	0.4	0.9	3.2	1.2	1.4	5.9	0.5	1.6	0.9	1.2	1.9	2.3	1.9	7.6	1.3	11.8	1.6	2.5	0.6	0.8	16.1	1.1	0.8	3.7	35.4	11.9	3.7	10.1	1.0	2.1	2.6	47.7	21.8	82.5	69.4	1.6	34.9	87.7	4.2	40.4	31.0	10.0	3.5	4.0	113.0	10.6	5.5	1.8	13.4	1.6	0.2	0.8	3.4	0.7	0.4	22.7	19.0	14.8	2.7	6.4	0.4	28.3	51.0	3.1	5.8	1.3	2.8	3.3	15.8	1.9	14.1	2.2	19.4	1.2	8.2	3.3	8.4	3.0	8.6	5.6	50.6	2.3	14.5	49.4	11.3	11.1	44.2	8.2	12.1	25.7	13.0	5.3	20.0	0.0	0.0	0.0	1.9	0.0	1.3	0.0	0.3	0.8	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.1	1.1	2.2	2.0	1.7	1.0	1.3	2.9	1.7	3.2	1.9	1.6	3.7	3.0	0.0	2.3	3.3	4.0	1.8	0.4	0.3	1.8	10.4	4.7	6.6	9.1	2.8	0.1	0.0	2.1	2.0	127.3	0.5	0.0	0.5	3.9	0.8	2.4	1.7	0.0	6.6	3.9	0.0	0.7	2.7	3.1	1.4	0.0	5.6	4.2	0.9	0.7	5.0	2.7	0.4	0.0	1.6	3.2	4.2	0.9	5.1	1.8	8.4	1.6	10.3	107.1	5.5	12.4	0.2	1.1	0.0	40.2	0.3	0.0	0.5	1.5	9.1	0.0	2.5	4.5	35.8	6.8	3.2	0.4	1.5	89.1	1.4	0.8	0.3
NCR3	"1C7, CD337, LY117, NKp30"	ENSG00000204475	"Natural cytotoxicity triggering receptor 3"	O14931	6	31588895-31593006	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 4.0;intestine: 5.6;lymphoid tissue: 16.1"	"Group enriched"	"Detected in some"	10	"B-cells: 43.6;dendritic cells: 110.4;NK-cells: 166.9;T-cells: 55.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 2.6"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 274.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.0;HEL: 2.7;NB-4: 10.9;U-698: 1.7"					"Low region specificity"	"Detected in many"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (3.99e-3)"	"unprognostic (9.23e-4)"	"unprognostic (1.23e-3)"	"unprognostic (2.49e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.57e-4)"	"unprognostic (5.99e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.43e-1)"	0.5	0.0	0.0	2.9	0.0	4.0	0.2	0.0	0.1	0.1	0.0	0.4	0.3	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.3	1.0	1.8	5.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.2	5.6	0.0	0.0	16.1	0.4	0.7	0.1	2.0	0.3	0.0	4.9	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.2	0.5	0.0	98.8	0.1	274.3	65.2	12.1	53.9	0.3	51.8	5.7	30.1	0.9	76.6	0.6	0.6	20.3	31.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.7	0.0	1.9	0.0	43.6	3.4	0.0	0.0	0.6	0.0	0.3	0.4	0.1	0.0	1.3	0.0	0.0	0.1	110.4	0.1	0.0	0.0	0.5	0.1	0.2	0.5	0.0	2.7	0.0	0.0	0.2	0.3	0.5	0.1	8.9	0.0	1.4	0.4	0.4	0.0	0.0	0.0	0.0	2.5	2.9	0.2	0.3	1.2	3.6	0.0	1.6	0.0	166.9	0.0	0.1	0.0	0.1	0.0	2.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.6	0.7	0.1	1.7	0.1	55.5	0.0	0.1	0.0
NOD2	"BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, PSORAS1"	ENSG00000167207	"Nucleotide binding oligomerization domain containing 2"	Q9HC29	16	50693588-50734041	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.6;esophagus: 11.7;skin 1: 14.4;vagina: 12.3"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 8.3;Kupffer cells: 9.0;Langerhans cells: 22.5;Macrophages: 15.2;monocytes: 15.6;Suprabasal keratinocytes: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"classical monocyte: 23.0;eosinophil: 6.0;intermediate monocyte: 13.1;myeloid DC: 21.3;neutrophil: 10.5;non-classical monocyte: 9.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 21.3;granulocytes: 10.5;monocytes: 23.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 11.6;T-47d: 5.8;THP-1: 7.3;U-266/70: 15.9;U-266/84: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041985, HPA054494"	Enhanced		Approved	"Golgi apparatus,Cytosol"		No	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Cytosol"		"HPA041985: AB_2677780, HPA054494: AB_2682505"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-3)"	"unprognostic (9.91e-3)"	"unprognostic (5.84e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.31e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	1.5	0.5	0.5	5.9	0.2	13.6	1.5	0.2	1.0	5.6	0.7	0.9	1.5	0.6	0.3	11.7	0.9	1.3	0.7	0.2	0.4	0.6	1.7	4.3	2.7	1.0	0.9	0.4	0.3	0.2	0.4	1.2	0.7	0.9	0.9	0.0	4.3	0.4	0.6	14.4	1.3	1.8	0.7	4.4	1.4	0.5	1.4	0.8	0.4	0.3	2.3	1.6	12.3	0.8	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	11.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.1	0.0	1.5	0.0	0.0	5.8	7.3	0.0	0.0	0.0	0.0	0.0	15.9	7.2	0.0	0.3	0.1	0.0	3.0	23.0	6.0	0.4	13.1	0.7	0.1	1.3	1.4	21.3	0.0	0.1	0.5	10.5	3.4	9.0	1.0	0.9	11.1	0.5	0.2	0.2	1.0	0.2	0.4	1.0	0.9	0.7	0.7	1.4	0.8	0.2	0.0	3.7	0.0	1.9	5.9	0.3	1.2	0.0	0.0	1.4	1.1	0.4	1.5	2.3	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	5.6	0.8	0.6	1.2	0.8	0.1	0.0	0.0	0.4	0.0	8.3	1.3	0.5	0.0	0.5	2.5	0.0	0.1	0.0	2.0	9.0	22.5	0.0	0.0	15.2	1.8	1.9	15.6	0.0	1.0	0.0	0.2	0.0	0.0	0.4	4.3	0.4	0.0	0.1	1.0	0.0	0.0	0.1	0.4	0.1	0.4	6.1	15.5	0.3	2.3	0.1	0.1	0.3
PRF1	"HPLH2, P1, PFP"	ENSG00000180644	"Perforin 1"	P14222	10	70597348-70602759	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Cytolysis		"Cancer-related genes, Disease variant, Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 28.6;lung: 16.5;lymphoid tissue: 49.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 542.1;NK-cells: 1231.7;T-cells: 265.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 900.4;MAIT T-cell: 628.8;memory CD8 T-cell: 499.1;naive CD8 T-cell: 313.0;NK-cell: 656.8"	"Group enriched"	"Detected in all"	50	"NK-cells: 656.8;T-cells: 900.4"	"Cell line enriched"	"Detected in some"	11	"HDLM-2: 240.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002436, HPA037940"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB002436: AB_563955, HPA037940: AB_2675747"	"unprognostic (6.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (6.98e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.69e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (7.38e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.97e-3)"	"unprognostic (5.22e-3)"	5.0	2.0	0.7	7.6	0.7	28.6	2.7	0.7	1.3	1.3	1.3	2.2	2.3	3.5	1.1	1.9	1.9	4.2	2.2	0.6	0.6	1.7	6.3	16.5	20.3	1.4	0.7	1.0	1.0	0.5	0.9	2.7	1.0	1.5	1.4	0.0	2.3	1.2	2.6	0.9	5.2	2.0	1.3	49.4	4.7	0.6	1.0	5.8	2.6	1.5	4.9	3.8	1.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	240.1	0.0	1.4	0.0	7.4	0.0	0.3	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	22.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	5.2	1.9	0.9	900.4	1.7	628.8	4.0	125.8	499.1	2.0	3.5	52.1	313.0	15.4	656.8	2.6	2.9	108.8	587.5	0.7	0.7	0.7	1.3	0.6	0.6	1.4	0.7	1.0	1.3	1.0	1.0	3.1	3.2	13.6	0.0	4.4	0.4	0.1	0.0	0.6	0.0	0.5	0.5	0.8	1.5	2.5	0.0	0.0	0.2	542.1	0.1	0.0	0.3	0.0	0.2	0.3	1.9	0.0	19.0	0.0	0.0	0.1	2.1	7.7	0.4	8.8	0.0	10.8	2.7	0.1	0.0	0.0	0.0	0.0	7.8	2.3	0.0	0.0	5.7	0.0	1.9	7.4	0.0	1231.7	0.0	0.1	0.0	0.0	0.0	88.5	0.1	0.1	1.6	1.5	0.0	0.0	1.1	0.8	0.0	0.0	0.5	0.9	0.7	265.4	0.0	0.1	0.0
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase receptor type C"	P08575	1	198638457-198757476	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Hydrolase, Protein phosphatase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 208.6;lymphoid tissue: 329.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 525.2;dendritic cells: 1026.4;Macrophages: 534.1;monocytes: 554.9;NK-cells: 769.3;Plasma cells: 474.2;T-cells: 1049.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 209.9;HEL: 118.0;HL-60: 108.1;JURKAT: 266.4;MOLT-4: 161.1;THP-1: 87.0;U-266/70: 93.7;U-266/84: 91.2;U-698: 123.4;U-937: 94.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		24000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.06e-2)"	32.8	11.6	3.8	248.5	3.3	208.6	13.9	4.4	4.3	14.9	6.9	26.4	27.4	11.3	5.6	15.1	8.4	45.7	7.3	3.5	5.6	7.0	29.6	68.6	329.9	12.9	8.6	5.7	5.6	4.0	2.9	23.5	11.5	11.6	30.5	2.0	13.8	6.6	4.6	5.7	42.9	25.3	7.9	202.5	37.9	5.5	6.9	306.9	7.0	7.6	251.2	62.1	5.2	14.7	0.4	0.0	0.2	0.2	0.0	0.0	0.8	0.3	0.3	0.1	0.0	0.0	0.1	209.9	0.3	0.7	0.2	0.3	0.0	0.2	0.4	0.6	0.0	118.0	0.2	0.1	0.0	108.1	0.7	0.0	0.0	0.3	0.0	0.4	0.5	266.4	2.4	3.3	0.3	0.1	161.1	65.0	0.5	0.2	0.2	4.6	0.4	0.3	0.1	0.1	1.2	1.8	0.1	0.4	0.5	0.2	0.3	87.0	1.3	0.0	0.8	0.8	0.4	93.7	91.2	123.4	0.1	94.5	0.4	226.1	480.0	521.4	634.4	885.8	541.8	249.0	437.0	618.1	385.8	245.8	489.8	494.1	844.3	506.9	1015.8	57.4	508.6	1340.6	3.8	3.3	4.4	4.3	3.5	5.6	12.9	8.6	11.5	7.9	6.9	14.7	12.6	44.8	62.3	0.7	525.2	15.8	0.9	0.0	4.0	0.3	6.0	9.3	4.6	5.7	14.2	1.8	0.0	0.6	1026.4	1.0	0.0	0.7	2.4	2.3	2.3	15.1	1.2	58.8	0.7	0.0	0.9	17.2	46.9	2.7	246.5	0.1	14.6	6.9	96.0	0.0	1.7	0.4	0.0	334.9	214.5	3.5	1.2	534.1	21.4	201.4	554.9	0.1	769.3	2.5	0.7	0.1	0.8	0.0	474.2	1.1	0.1	2.5	11.7	0.2	6.6	7.4	6.7	0.3	0.6	1.8	15.2	0.8	1049.1	5.4	0.9	0.8
PYHIN1	"IFIX, MGC23885"	ENSG00000163564	"Pyrin and HIN domain family member 1"	Q6K0P9	1	158930796-158977059	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 23.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 165.9;NK-cells: 324.4;T-cells: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"gdT-cell: 97.3;MAIT T-cell: 56.3;memory CD4 T-cell: 40.8;memory CD8 T-cell: 74.7;naive CD8 T-cell: 45.1;NK-cell: 36.8;T-reg: 67.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 36.8;T-cells: 97.3"	"Cell line enriched"	"Detected in some"	6	"U-698: 49.1"									"HPA051224, HPA055373"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoli	Nucleoplasm	"HPA051224: AB_2681394, HPA055373: "	"unprognostic (1.64e-3)"	"unprognostic (1.75e-3)"	"unprognostic (2.93e-3)"	"unprognostic (2.64e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.44e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-6)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.45e-3)"	2.3	0.6	0.2	8.3	0.3	5.5	1.2	0.2	0.4	1.0	0.4	1.7	1.6	1.1	0.8	0.8	0.9	3.8	0.6	0.3	0.4	0.7	3.2	3.7	23.1	0.7	0.3	0.8	0.3	0.2	0.3	0.9	0.6	1.0	2.1	0.1	1.6	0.5	0.3	0.5	5.4	0.7	0.2	13.9	2.7	0.4	0.5	3.7	1.4	0.6	12.5	3.3	0.8	1.2	0.0	0.0	0.0	0.0	0.7	0.4	0.6	0.0	0.2	0.0	0.1	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.1	0.1	0.0	0.0	0.9	0.0	49.1	0.0	7.7	0.0	1.5	0.3	0.4	97.3	0.4	56.3	14.8	40.8	74.7	0.3	8.7	13.5	45.1	3.5	36.8	0.5	0.6	67.3	21.0	0.2	0.3	0.2	0.4	0.3	0.4	0.7	0.3	0.6	0.2	0.5	1.2	1.3	12.8	2.8	1.0	17.0	0.4	0.6	0.0	0.0	0.5	1.2	0.9	0.6	0.0	2.0	3.7	0.0	0.1	165.9	0.1	0.0	0.1	0.3	0.5	0.3	1.2	0.0	7.4	0.5	0.0	0.0	2.7	2.6	0.2	2.5	0.1	3.9	1.2	2.7	0.0	0.5	0.0	0.0	5.0	1.5	0.3	0.0	3.5	1.8	6.5	2.3	0.5	324.4	0.0	0.2	0.0	0.0	0.0	37.9	0.6	0.0	0.6	5.3	1.1	0.0	0.7	0.7	0.1	0.2	0.1	0.6	0.1	104.7	0.0	0.2	0.4
SAMD3	"bA73O6.2, FLJ34032"	ENSG00000164483	"Sterile alpha motif domain containing 3"	Q8N6K7	6	130144315-130365425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 157.0;NK-cells: 271.9;Plasma cells: 43.7;T-cells: 84.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	47	"NK-cells: 128.4;T-cells: 113.8"	"Cell line enhanced"	"Detected in some"		"HBF TERT88: 1.8;HDLM-2: 3.4;hTEC/SVTERT24-B: 2.2;hTERT-RPE1: 1.9;NTERA-2: 1.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 2.1"	"HPA028992, HPA028993"	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA028992: AB_10598914, HPA028993: AB_10601891"	"unprognostic (2.91e-3)"	"unprognostic (5.35e-3)"	"unprognostic (4.15e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.48e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.42e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.07e-6)"	"unprognostic (7.09e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.45e-2)"	1.1	2.3	1.4	4.0	2.0	4.2	0.9	0.6	1.6	2.9	0.6	1.2	0.7	4.4	1.9	0.7	1.5	2.3	0.5	2.9	1.2	1.1	1.7	3.3	10.4	0.8	2.0	1.8	1.2	0.1	4.8	0.7	0.9	0.7	2.3	1.4	0.7	0.4	0.8	0.5	1.4	1.7	0.4	9.3	1.6	3.2	1.9	6.3	0.8	0.7	4.2	1.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.1	0.3	0.5	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.8	3.4	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.3	0.0	2.2	0.1	1.9	0.2	0.4	0.1	0.0	0.2	0.0	0.1	0.0	1.7	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.5	113.8	0.4	90.0	2.5	39.8	102.1	0.6	0.3	28.8	68.9	2.3	128.4	0.6	0.6	41.7	41.4	1.4	2.0	0.6	1.6	2.9	1.2	0.8	2.0	0.9	0.4	1.9	0.4	1.1	0.0	2.3	1.3	2.3	0.4	0.0	0.0	0.6	3.0	0.6	0.5	0.8	0.0	0.0	0.0	0.0	0.0	157.0	1.6	0.0	0.2	25.4	1.0	2.1	0.8	3.6	6.6	12.1	0.0	0.0	0.7	0.0	0.5	1.3	14.8	2.9	0.4	0.0	0.0	5.7	0.3	0.0	3.4	1.4	6.7	0.6	1.8	5.4	12.2	2.3	0.0	271.9	1.5	0.6	0.0	1.5	1.9	43.7	0.0	0.1	0.6	0.7	0.4	0.0	0.3	1.4	2.3	1.6	0.2	0.4	0.0	84.3	2.0	0.5	0.1
SH2D2A	"F2771, TSAd"	ENSG00000027869	"SH2 domain containing 2A"	Q9NP31	1	156806243-156816848	"Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 33.9;dendritic cells: 139.5;NK-cells: 113.3;T-cells: 103.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	30	"NK-cells: 28.5;T-cells: 66.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 46.5;HMC-1: 33.3;Karpas-707: 81.0;RPMI-8226: 24.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 3.5;hippocampal formation: 1.6"	HPA074482	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA074482: "	"prognostic favorable (4.96e-4)"	"unprognostic (2.76e-2)"	"unprognostic (7.50e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.14e-3)"	"unprognostic (2.73e-1)"	"unprognostic (3.11e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.34e-3)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (5.26e-12)"	"unprognostic (1.67e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.79e-1)"	"prognostic favorable (1.31e-4)"	3.5	0.9	1.0	11.4	1.1	4.3	1.3	3.8	1.6	1.8	1.9	2.2	2.5	1.7	0.3	1.2	1.5	3.3	2.5	0.9	1.5	2.5	2.2	5.4	9.4	1.9	1.1	0.6	1.0	0.3	1.8	0.8	1.5	2.5	2.0	3.4	0.9	0.7	0.4	0.4	5.4	1.6	1.2	13.0	2.9	0.3	1.1	14.9	1.6	0.0	5.9	3.7	1.2	1.3	2.6	0.4	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	1.7	2.4	0.0	6.8	0.0	0.0	0.0	0.4	1.3	0.1	46.5	0.1	6.8	0.5	0.9	0.2	0.4	33.3	0.5	0.0	0.2	3.3	0.0	0.3	11.8	1.9	81.0	0.0	0.2	5.9	0.7	4.9	4.1	8.3	0.9	0.0	24.5	0.1	0.3	7.5	0.0	1.6	0.9	0.8	0.5	0.2	1.3	2.2	0.0	0.0	0.3	0.5	11.6	16.6	8.3	0.0	6.9	0.2	1.0	0.1	0.0	66.5	0.0	61.8	1.1	27.6	40.8	0.1	0.3	10.4	27.2	1.5	28.5	0.2	0.1	34.1	18.6	1.0	1.1	3.8	1.6	0.9	1.5	1.9	1.1	1.5	1.2	1.1	1.3	1.2	3.2	2.3	0.0	4.6	2.2	0.3	0.4	1.2	33.9	1.0	1.9	0.9	0.0	1.3	0.0	0.0	0.1	139.5	1.2	0.0	0.3	0.2	0.2	2.5	0.6	1.2	6.1	0.0	0.6	1.0	4.8	9.2	0.5	8.2	0.3	1.8	0.9	1.1	0.0	0.0	0.9	0.0	1.9	2.1	0.0	0.0	4.1	0.0	1.9	1.1	1.3	113.3	0.0	0.5	6.1	1.4	0.0	24.2	0.5	0.3	0.2	0.7	1.6	0.0	0.5	2.9	0.1	4.9	3.0	1.3	0.1	103.2	0.1	1.8	0.5
SLA2	"C20orf156, FLJ21992, SLAP-2"	ENSG00000101082	"Src like adaptor 2"	Q9H6Q3	20	36612318-36646196	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.5;lymphoid tissue: 18.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 97.0;Macrophages: 21.8;NK-cells: 44.3;Plasma cells: 25.8;T-cells: 59.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"gdT-cell: 28.8;MAIT T-cell: 24.1;memory CD4 T-cell: 23.8;memory CD8 T-cell: 27.1;naive CD4 T-cell: 21.8;naive CD8 T-cell: 30.5;NK-cell: 39.2;plasmacytoid DC: 48.5;T-reg: 33.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 48.5;NK-cells: 39.2;T-cells: 33.4"	"Group enriched"	"Detected in some"	7	"HEL: 91.2;JURKAT: 51.8"	"Not detected"	"Not detected"							"HPA053746, HPA058217"			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA053746: AB_2682246, HPA058217: AB_2683641"	"unprognostic (4.16e-3)"	"prognostic favorable (7.36e-4)"	"unprognostic (4.52e-4)"	"unprognostic (2.30e-6)"	"unprognostic (3.37e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.77e-8)"	"unprognostic (8.48e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.45e-3)"	1.3	0.6	0.4	5.7	0.6	12.5	0.8	1.6	0.7	0.8	0.3	1.7	2.7	1.0	0.5	0.7	0.9	2.4	0.7	0.4	0.2	0.5	1.5	4.1	10.4	0.7	0.4	0.4	0.4	0.1	0.4	0.6	0.8	0.7	1.7	0.5	1.4	0.5	0.6	0.7	3.1	0.5	0.3	8.0	2.6	0.5	0.6	18.3	0.7	0.2	9.0	2.2	0.6	1.1	0.0	0.2	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	91.2	0.6	3.4	0.0	2.5	0.3	0.1	0.1	0.0	0.0	0.0	0.1	51.8	0.1	0.2	0.0	0.2	10.9	7.6	0.1	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	2.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.1	7.6	0.1	3.0	0.4	3.8	28.8	0.7	24.1	0.4	23.8	27.1	0.4	0.3	21.8	30.5	4.8	39.2	0.1	48.5	33.4	26.5	0.4	0.6	1.6	0.7	0.4	0.2	0.7	0.4	0.8	0.3	0.6	1.1	0.6	0.0	3.9	0.0	1.6	0.4	0.1	0.0	0.0	0.3	0.5	0.3	0.3	0.0	0.7	0.0	0.0	0.1	97.0	0.6	0.0	0.2	1.1	0.4	0.4	0.4	0.0	8.2	2.2	0.0	0.2	0.5	4.1	0.6	1.3	0.0	0.7	0.1	0.2	0.0	1.7	0.0	0.0	1.6	0.4	0.0	0.3	21.8	0.0	1.9	1.2	0.4	44.3	1.5	1.4	0.3	0.1	0.0	25.8	0.1	0.0	0.1	0.0	0.9	0.0	0.3	0.4	0.0	0.2	0.2	0.1	0.1	59.2	0.0	0.2	0.3
TKTL1	"TKR, TKT2"	ENSG00000007350	"Transketolase like 1"	P51854	X	154295795-154330350	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"testis: 127.1"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 166.9;Spermatogonia: 491.5"	"Cancer enriched"	"Detected in many"	8	"testis cancer: 44.2"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 4.3;medulla oblongata: 1.7"	"Group enriched"	"Detected in many"	5	"eosinophil: 60.9;gdT-cell: 24.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 60.9;T-cells: 24.4"	"Cell line enriched"	"Detected in some"	163	"THP-1: 495.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"white matter: 1.2"	"HPA000505, HPA029155, CAB032191"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"CAB032191: , HPA000505: AB_1858022, HPA029155: AB_10603134"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.38e-1)"	0.3	0.1	0.3	0.4	0.4	0.9	0.2	0.2	4.3	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	3.8	0.3	0.3	0.3	0.2	1.0	0.4	1.7	0.2	0.1	0.0	0.0	0.9	0.3	0.6	0.1	0.0	2.2	0.0	0.0	0.3	0.2	0.1	0.1	0.5	0.7	0.0	127.1	0.5	0.4	0.1	0.5	0.1	0.1	0.1	0.5	0.3	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.0	0.0	495.2	0.0	0.0	0.0	0.1	0.2	0.0	3.0	2.7	0.0	0.0	0.4	1.6	0.1	60.9	24.4	0.4	3.5	0.1	2.9	2.2	0.0	0.1	6.0	5.4	1.0	7.8	0.3	0.2	3.5	5.8	0.3	0.4	0.2	4.3	0.3	0.3	1.7	0.2	0.6	0.5	0.5	0.5	0.2	0.0	0.0	0.7	0.5	0.3	0.0	0.0	0.6	0.3	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	44.8	0.0	0.1	0.7	0.0	0.4	0.4	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.1	0.2	25.2	0.4	0.0	0.0	0.3	3.7	22.5	4.1	1.9	0.0	1.0	0.6	6.0	20.6	1.0	0.1	0.0	0.0	1.9	1.3	0.0	0.0	0.1	0.0	1.0	26.3	1.4	1.6	166.9	491.5	0.1	0.1	0.0	4.1	0.1	0.0	0.0
TMEM71	FLJ33069	ENSG00000165071	"Transmembrane protein 71"	Q6P5X7	8	132685007-132760712	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.5;heart muscle: 37.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 39.9;Kupffer cells: 20.7;Langerhans cells: 25.7;Macrophages: 26.2;monocytes: 25.5;NK-cells: 54.6;T-cells: 35.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 9.7"	"Immune cell enhanced"	"Detected in all"		"neutrophil: 269.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 269.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 12.7;HDLM-2: 54.5;Karpas-707: 11.1;U-937: 31.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058401, HPA070655"	Uncertain		Enhanced	Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria		"HPA058401: AB_2683707, HPA070655: AB_2686292"	"unprognostic (1.39e-3)"	"unprognostic (7.27e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.10e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.29e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.73e-1)"	5.6	2.0	1.0	13.1	1.3	33.5	8.5	1.0	9.7	2.5	2.2	11.3	2.2	1.3	1.1	2.8	1.9	5.5	37.1	1.1	1.8	2.6	3.9	8.2	13.2	1.6	1.3	1.0	2.4	0.7	1.1	1.8	2.1	2.0	3.4	0.5	5.7	2.2	1.6	1.1	7.3	3.6	1.1	18.4	2.8	1.0	2.4	19.2	2.0	4.6	10.6	4.6	1.9	1.6	0.4	0.0	4.9	0.0	0.0	0.0	0.0	1.3	12.7	0.5	0.9	0.0	0.0	0.1	0.6	4.1	0.1	0.0	0.0	0.3	1.5	54.5	0.0	0.0	0.0	0.0	0.3	3.6	0.0	0.1	0.0	0.1	2.0	1.4	1.0	6.7	0.0	11.1	2.4	0.0	2.9	2.2	1.2	0.0	0.4	0.1	1.8	0.8	4.8	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.1	2.1	0.5	0.9	1.2	5.7	0.1	2.9	0.0	9.0	31.6	3.7	61.9	55.9	101.6	31.3	16.1	57.9	6.6	22.8	22.2	33.7	4.7	33.9	25.1	269.0	12.9	14.7	1.1	3.0	39.0	1.0	1.3	1.0	9.7	1.1	1.8	1.6	1.3	2.1	1.1	2.4	1.6	0.5	0.0	3.0	0.0	6.9	0.9	1.0	2.5	0.6	0.0	4.2	2.7	15.9	0.0	5.5	0.0	0.0	0.0	39.9	0.1	0.0	0.0	6.5	0.1	0.3	1.5	0.0	8.8	0.5	0.0	0.0	4.1	1.1	0.2	1.3	0.0	3.3	0.2	3.2	0.0	1.3	0.2	0.0	20.7	25.7	5.1	0.0	26.2	5.4	17.8	25.5	1.9	54.6	0.0	0.1	0.1	0.0	0.0	11.3	0.1	0.0	0.4	2.9	0.0	0.0	3.7	0.8	0.0	0.6	0.4	0.3	0.3	35.9	0.1	0.0	4.5
TRDC		ENSG00000211829	"T cell receptor delta constant"		14	22462932-22465787	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	15	"lymphoid tissue: 404.4"	"Cell type enriched"	"Detected in some"	4	"NK-cells: 746.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 19.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	87	"gdT-cell: 5873.4;NK-cell: 2243.9"	"Group enriched"	"Detected in all"	150	"NK-cells: 2243.9;T-cells: 5873.4"	"Cell line enriched"	"Detected in some"	38	"NB-4: 356.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (1.21e-3)"	"unprognostic (8.15e-3)"	"unprognostic (7.03e-2)"	"prognostic favorable (8.25e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (6.13e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.67e-5)"	"unprognostic (1.25e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.99e-2)"	13.4	0.4	1.3	7.8	1.0	26.2	3.8	1.4	1.4	2.9	0.6	8.9	3.9	7.6	2.1	2.0	4.1	7.9	2.7	2.0	0.9	1.1	11.1	11.6	22.7	0.9	1.2	1.9	0.2	0.4	0.7	2.8	0.8	1.0	7.5	0.0	4.6	1.2	1.6	1.3	5.6	2.2	0.7	54.2	2.0	2.7	0.9	404.4	1.8	1.3	18.3	4.6	0.9	1.3	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	356.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.0	3.1	0.9	1.4	0.0	0.0	0.1	3.2	4.8	2.3	5873.4	7.9	3.8	5.7	16.7	31.7	9.2	1.9	16.2	46.6	27.0	2243.9	5.5	7.1	27.5	1292.0	1.3	1.0	1.4	1.4	2.0	0.9	0.9	1.2	0.8	0.7	0.9	1.3	1.1	3.2	5.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.6	0.0	0.0	0.0	165.7	0.3	0.0	0.5	0.0	0.9	0.8	0.7	0.0	1.3	0.0	0.0	0.0	1.3	0.0	1.0	0.0	0.0	4.2	0.5	0.5	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.9	0.0	0.0	5.7	0.0	746.6	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	123.5	0.0	0.0	0.0
TRGC1	"C1, TCRGC1"	ENSG00000211689	"T cell receptor gamma constant 1"		7	38257879-38265678	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	8	"bone marrow: 31.7;prostate: 76.6"	"Group enriched"	"Detected in some"	5	"dendritic cells: 95.8;NK-cells: 230.7;Prostatic glandular cells: 61.9;T-cells: 65.6"	"Cancer enriched"	"Detected in some"	141	"prostate cancer: 107.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"gdT-cell: 384.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 384.7"	"Cell line enhanced"	"Detected in some"		"HL-60: 21.0;MCF7: 89.8;SK-BR-3: 49.6;U-937: 45.5"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (2.37e-2)"	"unprognostic (2.38e-4)"	"unprognostic (3.43e-3)"	"unprognostic (6.04e-4)"	"unprognostic (1.04e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.33e-3)"	"unprognostic (3.80e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.56e-2)"	0.6	0.2	1.6	1.1	1.6	31.7	2.1	1.4	2.0	0.1	1.1	0.5	1.0	0.2	0.5	0.1	0.3	1.0	0.2	1.4	1.4	0.8	0.8	1.9	2.0	1.7	1.5	0.1	0.0	0.0	0.2	0.5	1.6	76.6	0.6	0.0	0.4	0.2	0.1	0.1	1.4	0.2	1.6	6.0	0.6	0.4	2.1	7.0	0.3	0.0	1.3	0.6	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	21.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	89.8	0.2	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	49.6	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	45.5	0.0	3.8	0.3	0.5	384.7	0.4	56.7	0.2	6.8	33.5	0.3	0.0	2.3	21.7	1.8	87.5	0.3	0.5	0.1	43.7	1.6	1.6	1.4	2.0	1.4	1.4	1.7	1.5	1.6	1.6	2.1	1.5	0.5	0.0	1.1	0.0	2.1	0.0	1.3	0.0	0.0	0.0	1.8	0.6	0.2	0.0	0.6	0.0	0.0	0.0	95.8	0.1	0.0	0.0	2.3	0.0	0.1	0.5	1.2	2.7	0.0	0.0	0.0	0.5	0.5	0.1	0.0	0.0	2.2	0.9	0.1	0.0	0.0	0.2	0.0	1.9	0.0	0.9	0.0	2.1	0.0	0.0	19.5	0.0	230.7	0.0	0.0	0.0	0.0	0.0	14.3	61.9	0.0	0.3	0.7	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	65.6	0.0	0.3	1.2
TRGV10	"TCRGV10, V3P"	ENSG00000211694	"T cell receptor gamma variable 10 (non-functional)"		7	38299811-38300322	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.1;lymphoid tissue: 13.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 7.5;Plasma cells: 7.1;T-cells: 29.9"	"Cancer enriched"	"Detected in many"	8	"prostate cancer: 7.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 196.5"	"Lineage enriched"	"Detected in many"	8	"T-cells: 196.5"	"Group enriched"	"Detected in some"	24	"NB-4: 79.7;U-937: 20.5"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (1.59e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.22e-4)"	"unprognostic (2.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.24e-4)"	"unprognostic (2.68e-1)"	"unprognostic (9.00e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.07e-2)"	1.7	0.6	0.1	2.7	0.3	14.1	1.8	0.1	0.4	1.2	0.6	2.0	2.1	0.8	0.7	1.1	1.3	3.3	0.4	0.0	0.1	0.6	1.8	4.1	11.0	0.4	0.1	0.3	0.2	0.1	0.2	0.4	0.3	6.1	2.7	0.0	1.1	0.7	0.2	0.6	4.1	0.6	0.2	13.9	2.6	0.3	0.2	12.5	1.1	0.0	5.0	3.8	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	79.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	20.5	0.0	0.7	0.4	1.0	196.5	0.1	156.1	0.5	47.2	137.6	0.2	0.1	11.3	159.7	2.9	26.0	0.3	0.8	0.1	33.3	0.1	0.3	0.1	0.4	0.0	0.1	0.4	0.1	0.3	0.2	0.2	0.3	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	29.9	0.0	0.0	0.0